Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-692-2 | CAS number: 1474044-73-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993-03-11 - 1993-04-22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study without deviations on ‘1,3,4-Thiadiazolidine-2,5-dithione, reaction products with hydrogen peroxide and tert-dodecanethiol’.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Umweltministerium Baden-Württemberg, Stuttgart, Germany
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- There was a OECD 406 available which had been performed in 1993. It fulfills all the criteria and there was no need to do further animal testing (LLNA)
Test material
- Reference substance name:
- 5-[(2,2-dimethyldecyl)disulfanyl]-1,3,4-thiadiazole-2-thiol; bis[(2,2-dimethyldecyl)disulfanyl]-1,3,4-thiadiazole
- EC Number:
- 939-692-2
- Cas Number:
- 1474044-73-9
- Molecular formula:
- not applicable (UVCB substance)
- IUPAC Name:
- 5-[(2,2-dimethyldecyl)disulfanyl]-1,3,4-thiadiazole-2-thiol; bis[(2,2-dimethyldecyl)disulfanyl]-1,3,4-thiadiazole
- Test material form:
- other: liquid
- Details on test material:
- - Physical state: light-brown liquid
- Stability under test conditions: stable at dry storage (20 °C)
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright White
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Interfauna, Süddeutsche Versuchstierfarm, Tuttlingen, Germany
- Age at study initiation: younger than 1 year
- Weight at study initiation: 333 g (males), 273 g (females), mean values
- Housing: individually in Macrolon cages (area 780 cm²)
- Diet: Raiffeisen-Ringfutter, dry food 52/P (Raiffeisen Kraftfutterwerk Kehl, Germany), ad libitum
- Water: community tap water supplemented with 20 mg/100 mL L-ascorbic acid and 100 mg/100 mL citric acid, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Pilot study: sesame oil (Carl Roth GmbH&Co., item No. 9335); Main study: unchanged (no vehicle)
- Concentration / amount:
- Pilot study: 12.5 %, 25 %, 50 %, 100 %
Main study: 100 % for induction and challenge
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Pilot study: sesame oil (Carl Roth GmbH&Co., item No. 9335); Main study: unchanged (no vehicle)
- Concentration / amount:
- Pilot study: 12.5 %, 25 %, 50 %, 100 %
Main study: 100 % for induction and challenge
- No. of animals per dose:
- Pilot study: 2
Main study: 10 (5 males and 5 females) - Details on study design:
- PILOT STUDY:
- No. of exposures: 1
- Exposure period: 6 h
- Site: clipped and covered by occlusive bandage
- Concentrations: 0.3 mL of 0%, 12.5%, 50%, 100%
- Evaluation: 1, 24, 48 and 72 h after application
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 6 h
- Test groups: test substance
- Control group: untreated
- Site: clipped area of 4x6 cm² of the left flank (24 h before application), covered with occlusive bandage made of an impermeable plastic tape and an elastic gauze
- Frequency of applications: every 7 days
- Duration: 14 days
- Concentrations: 100% (0.3 mL)
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 28
- Exposure period: 6 h
- Test groups: test substance
- Control group: test substance
- Site: clipped area of 4x6 cm² of the right flank (24 h before application), covered with occlusive bandage made of an impermeable plastic tape and an elastic gauze
- Concentrations: 100% (0.3 mL)
- Evaluation (hr after challenge): 24 and 48 h after application - Challenge controls:
- No information available.
- Positive control substance(s):
- not specified
- Remarks:
- No positive control substance recorded.
Results and discussion
- Positive control results:
- Not applicable.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
Result of pilot study:
Skin reactions: | |||||
Time after application | |||||
Concentration | Animal No. | 1 h | 24 h | 48 h | 72 h |
12.50% | 1 | none | none | none | none |
2 | none | none | none | none | |
25.00% | 1 | none | none | none | none |
2 | none | none | none | none | |
50.00% | 1 | none | none | none | none |
2 | none | none | none | none | |
100.00% | 1 | none | none | none | none |
2 | none | none | none | none | |
control | 1 | none | none | none | none |
2 | none | none | none | none |
None of the animals died or showed signs of toxicological symptoms. The behaviour pattern was not different to that of non treated guinea pigs (control).
Main study:
Body weight (g) on day | ||||||||||
Animal Number | -5 | 0 | 7 | 14 | 21 | 28 | 29 | 30 | ||
Test Group | Males | 11 | 332 | 380 | 425 | 479 | 510 | 590 | 587 | 587 |
12 | 367 | 433 | 461 | 518 | 530 | 580 | 585 | 586 | ||
13 | 329 | 372 | 400 | 457 | 479 | 613 | 624 | 623 | ||
14 | 335 | 378 | 418 | 431 | 458 | 530 | 544 | 545 | ||
15 | 329 | 378 | 416 | 472 | 507 | 566 | 547 | 546 | ||
mean | 338 | 388 | 424 | 391 | 497 | 576 | 577 | 577 | ||
Females | 16 | 200 | 247 | 240 | 272 | 320 | 418 | 425 | 425 | |
17 | 243 | 300 | 337 | 394 | 416 | 518 | 500 | 503 | ||
18 | 300 | 310 | 314 | 385 | 412 | 508 | 507 | 510 | ||
19 | 244 | 265 | 310 | 355 | 389 | 452 | 455 | 455 | ||
20 | 212 | 260 | 275 | 348 | 359 | 485 | 470 | 469 | ||
mean | 240 | 276 | 295 | 351 | 379 | 476 | 471 | 472 | ||
Control Group | Males | 21 | 265 | 305 | 330 | 355 | 418 | 481 | 502 | 505 |
22 | 327 | 359 | 400 | 150 | 479 | 576 | 567 | 570 | ||
23 | 348 | 384 | 412 | 474 | 499 | 552 | 558 | 558 | ||
24 | 327 | 335 | 370 | 437 | 458 | 531 | 545 | 545 | ||
25 | 349 | 400 | 449 | 515 | 540 | 647 | 646 | 647 | ||
mean | 323 | 357 | 392 | 386 | 479 | 557 | 564 | 565 | ||
Females | 26 | 280 | 325 | 350 | 410 | 447 | 500 | 507 | 510 | |
27 | 289 | 332 | 368 | 424 | 450 | 519 | 530 | 528 | ||
28 | 265 | 312 | 350 | 391 | 428 | 442 | 500 | 499 | ||
29 | 337 | 353 | 370 | 399 | 432 | 402 | 468 | 470 | ||
30 | 352 | 395 | 441 | 480 | 516 | 528 | 565 | 567 | ||
mean | 305 | 343 | 376 | 421 | 455 | 478 | 514 | 515 |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Criteria used for interpretation of results: EU-GHS
- Conclusions:
- The study was conducted according to OECD Guideline 406 and is considered as valid. The control group also showed no skin reactions.
As no animal in the test group showed any skin reaction after application of the test substance a classification is not required, neither according to EU Directive 67/548/EEC nor according to EC Regulation 1272/2008. The test item can be regarded as non-sensitising. - Executive summary:
The test substance (1,3,4-Thiadiazolidine-2,5-dithione, reaction products with hydrogen peroxide and tert-dodecanethiol) was tested in a GLP study according to OECD Guideline 406 for its sensitising potential in order to determine whether there is any specific (sensitising) or non-specific (irritant) stimulating potential of the test substance (Biochem, Grunert, 1993). In a pilot study the test item was tested dermally, occlusive and thinned to 12.5 %, 25 %, 50 % and 100 % in sesame oil over a period of 6h with a single exposure. Each dose group consisted of 2 guinea pigs (Pirbright White, age < 1a), an area of 4 cm x 6 cm was clipped and exposed to 0.3 mL of the test item, the post-exposure period was 72 h. Additionally, a control group was not exposed to the test item. After 1 h, 1 d, 2 d and 3 d the treated skin was checked for irritation. At no time point and in no animal any skin reactions were observed. Therefore, the undiluted test item was chosen for the main study. In the main study, a test group and a control group consisting each of 10 guinea pigs (5 males / 5 females) were used. The test group was exposed occlusive during the induction phase three times (day 0, 7, 14) over 6 h to 0.3 ml the test item onto 4 cm x 6 cm clipped skin. The control group was not exposed to the test item but was treated the same way regarding clipping and the occlusive bandage. After two weeks free from all treatment the test item was applied similar to the induction phase on day 28 to both groups (test animals as well as control animals) over 6 h. 24 h and 48 h after the challenge skin readings were performed. No animal, neither control nor test group, exhibited any skin reaction. Therefore, the substance can be regarded as non-sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
